Home › Schizophrenia › Tennessee
Schizophrenia clinical trials in Tennessee
6 studies for Schizophrenia are looking for participants at sites in Tennessee.
Cities in Tennessee
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Access Clinical Trials, Nashville
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0137, Nashville
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT07424404A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Local Institution - 0113, Nashville
RecruitingPhase 3
Ages 13 to 17 · All sexes · Updated Sep 4, 2026 · NCT07288567Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0051, Cordova
- Psychiatric Consultants, Pc, Franklin
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
- Vanderbilt Psychiatric Hospital, Nashville
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Jun 2, 2026 · NCT07196462Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 to 65 · All sexes · Updated May 6, 2026 · NCT06835556From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.